德国巴登-符腾堡-黑森州红十字会献血服务中心启动研究,评估Cerus公司Intercept™血液系统处理病原体灭活血小板浓缩剂在常规临床实践中的应用

美股速递
Jan 22

德国巴登-符腾堡-黑森州红十字会献血服务中心已正式启动一项研究项目,旨在评估采用Cerus公司Intercept™血液系统处理过的病原体灭活血小板浓缩剂在常规临床实践中的实际应用效果。该研究将重点关注该技术在临床环境下的安全性和有效性,为血液制品的病原体灭活处理提供重要的实践依据。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10